In 1998, Liang et al. (15) discovered the BCL2 binding protein beclin 1, a mammalian homolog of yeast ATG6. In 2003, they further demonstrated that beclin 1 had tumor-suppressing properties (16). The gene discussed is BECN1; the disease is neoplasm.